Cipla

Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company's Global Chief Financial Officer.

Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

Delhi HC questions govt over urgency to ban over 300 FDC drugs

Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla

Delhi HC extends relief to pharma firms over drug ban

Several companies went to the Delhi High Court to try to get the ban lifted

11 stocks trending in Friday’s trade: Crompton Greaves, DLF and more

Healthcare majors, including Cipla, Lupin, Wockhardt, Glaxosmithkline and Mankind Pharma, on Thursday granted interim relief by Delhi High Court which stayed till March 21 the ban imposed by the Centre on sale of some of thei

11 stocks trending in Friday’s trade: Crompton Greaves, DLF and more

Cipla invests additional $ 3mn in US’s Chase Pharmaceuticals

Cipla in May 2014 had invested $1.5 million to acquire 14.6 per cent stake in Chase Pharmaceuticals.

Cipla invests additional $ 3mn in US’s Chase Pharmaceuticals

Cipla completes acquisition of generic businesses in US

The acquisition will provide a launch pad to introduce Cipla’s pipeline of products in respiratory and injectables, among others, in the coming years Cipla’s UK arm, Cipla (EU) has closed the transaction to acquire tw

Cipla posts PAT of Rs 343 crore in Q3 FY1516

Domestic sales reduced to Rs 1,194 crore Cipla announced its unaudited consolidated financial results for the quarter ended December 31, 2015 (Q3). Income from operations grew by 12.3 per cent to Rs 3,107 crore, up from Rs. 2

Cipla patriarch Y K Hamied increases stake in company to over 20 per cent

Acquires additional five per cent stake from his wife Farida Hamied In a move aimed at realignment of family shareholding, Cipla patriarch YK Hamied has increased his stake in the homegrown drug major to over 20 per cent by a

Cipla gets CCI nod to sell stake in consumer healthcare business

In November last year, the company signed an agreement to sell 26.11 per cent in Cipla Health to FIL Capital Investments (Mauritius) II Cipla has received approval from fair trade regulator CCI to sell about 26 per cent stake

SC admits Cipla’s plea for expert appointment in Hoffmann-La Roche patent row

In Nov, the Delhi HC, while holding Cipla guilty of infringing Roche’s patent over lung cancer drug Erlotinib, had held that its Erlocip violated the patent rights of Hoffman-La Roche

Top 10 stocks that trended in today’s trade: SpiceJet, Interglobe Aviation, Supreme Petrochem and more

SpiceJet shares closed 11.22 per cent up at Rs 78.80 after the company posted a net profit of Rs.238.39 crore in the December quarter, against a net loss of Rs.275.02 crore in the year-ago period.

Top 10 stocks that trended in today’s trade: SpiceJet, Interglobe Aviation, Supreme Petrochem and more

Cipla announces new management council

Appoints Umang Vohra as its Global Chief Operating Officer Cipla announced the creation of a six member Management Council that will be the apex executive leadership team for the company. This is part of its ongoing transform

Cipla inks pact with US firm for Ropivacaine infusion system

Drug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of latter's Ropivacaine infusion system, used in treating post-operative pain, in India.

Cipla inks pact with US firm for Ropivacaine infusion system

Cipla launches anti-ageing skin care product Cutisera

Cutisera has been developed by Stempeutics Cipla has launched a novel “5 in 1” anti-ageing skin care product Cutisera developed by Stempeutics. Cutisera has been developed using bio-active factors derived from human adult

Cipla ready to launch low-dose Efavirenz 400 mg

Studies found that the reduced dose of 400 mg Efavirenz was non-inferior to the standard dose of 600 mg Efavirenz dose

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement

TRENDING NOW

BUDGET 2019

Related Articles

FinancialExpress_1x1_Imp_Desktop